Association between road traffic accidents and drugs belonging to the antiseizure medications class: A pharmacovigilance analysis in VigiBase
- PMID: 35939367
- DOI: 10.1111/bcp.15481
Association between road traffic accidents and drugs belonging to the antiseizure medications class: A pharmacovigilance analysis in VigiBase
Abstract
Aims: Due to their central mechanism of action, antiseizure medications (ASMs) could lead to adverse effects likely to impair driving skills. Their extended use to neuropsychiatric disorders makes it a class of drugs to monitor for their road traffic accidental (RTA) potential. We aimed to assess the reporting association between ASMs and RTAs using the World Health Organization pharmacovigilance database (VigiBase).
Methods: We performed a disproportionality analysis to compute adjusted reporting odds ratios to evaluate the strength of reporting association between ASMs and RTAs. A univariate analysis using the reporting odds-ratio was used to assess drug-drug interactions between ASMs and RTAs.
Results: There were 1 341 509 reports associated with at least 1 ASM in VigiBase of whom 2.91‰ were RTAs reports. Eight ASMs were associated with higher reporting of RTAs compared to others (ranging from 1.35 [95% confidence interval 1.11-1.64] for lamotrigine to 4.36 [95% confidence interval 3.56-5.32] for cannabis). Eight significant drug-drug interactions were found between ASMs and the onset of RTA, mainly involving CYP450 induction.
Conclusion: A significant safety signal between RTAs and some ASMs was identified. Association of several ASMs might further increase the occurrence of RTA. ASMs prescription in patients with identified risk factors of RTA should be considered with caution. Study number: ClinicalTrials.gov, NCT04480996.
Keywords: CYP450 inductors; antiseizure medications; drug-drug interactions; gabapentinoids; pharmaco-epidemiology; road traffic accidents.
© 2022 British Pharmacological Society.
References
REFERENCES
-
- Sirven JI, Noe K, Hoerth M, Drazkowski J. Antiepileptic Drugs 2012: Recent Advances and Trends. Mayo Clin Proc. 2012;87(9):879-889. doi:10.1016/j.mayocp.2012.05.019
-
- Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord. 2004;6(2):57-75.
-
- Devlin AL, Odell M, Charlton LJ, et al. Epilepsy and driving: Current status of research. Epilepsy Res. 2012;102(3):135-152. doi:10.1016/j.eplepsyres.2012.08.003
-
- Orriols L, Foubert-Samier A, Gadegbeku B, et al. Prescription of antiepileptics and the risk of road traffic crash. J Clin Pharmacol. 2013;53(3):339-344. doi:10.1002/jcph.10
-
- Andrew T, Milinis K, Baker G, Wieshmann U. Self reported adverse effects of mono and polytherapy for epilepsy. Seizure. 2012;21(8):610-613. doi:10.1016/j.seizure.2012.06.013
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
